Impact of pexelizumab, an anti-C5 complement antibody, on total mortality and adverse cardiovascular outcomes in cardiac surgical patients undergoing cardiopulmonary bypass
Titel:
Impact of pexelizumab, an anti-C5 complement antibody, on total mortality and adverse cardiovascular outcomes in cardiac surgical patients undergoing cardiopulmonary bypass
Auteur:
Shernan, Stanton K Fitch, Jane C.K Nussmeier, Nancy A Chen, John C Rollins, Scott A Mojcik, Christopher F Malloy, Kevin J Todaro, Thomas G Filloon, Thomas Boyce, Steven W Gangahar, Deepak M Goldberg, Michael Saidman, Lawrence J Mangano, Dennis T